Effects of epicardial versus transvenous left ventricular lead placement on left ventricular function and cardiac perfusion in cardiac resynchronization therapy: A randomized clinical trial
- PMID: 28471012
- DOI: 10.1111/jce.13242
Effects of epicardial versus transvenous left ventricular lead placement on left ventricular function and cardiac perfusion in cardiac resynchronization therapy: A randomized clinical trial
Abstract
Introduction: Optimal left ventricular (LV) lead position in patients undergoing cardiac resynchronization therapy (CRT) is crucial to achieve an optimal effect on hemodynamics. Due to various difficulties, up to 30% of transvenous LV lead placements fail, or a suboptimal position is achieved. Surgical epicardial LV lead placement could be performed at a position anticipated to be the optimal site. This could have a more favorable effect, which may be expressed by increased improvement in left ventricular ejection fraction (LVEF) and cardiac perfusion. The objective of this trial is to compare transvenous versus epicardial LV lead placement in CRT in a randomized fashion METHODS AND RESULTS: Fifty-two patients were randomized to either epicardial or transvenous approach. All patients received an ICD with CRT. Patients were followed for 6 months after device implant. Primary endpoint was the degree of change in cardiac perfusion measured by myocardial perfusion scintigraphy. LVEF equally improved in both groups, from 24% to 36% in the transvenous group versus 25% to 35% in the epicardial group (P = 0.797). Cardiac perfusion, expressed as summed stress score, improved in both groups without a significant difference as well (P = 0.727). Complication rate was similar, respectively 6 and 7 patients had any complication. Admission time was significantly longer in the epicardial group with 2 (2-7) versus 3 (2-32) days (P <0.001).
Conclusion: Epicardial LV lead placement does not result in additional improvement of LVF or myocardial perfusion compared to the conventional transvenous in CRT.
Keywords: ICD; LV lead; cardiac resynchronization therapy; epicardial lead; myocardial perfusion.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.Europace. 2019 Sep 1;21(9):1369-1377. doi: 10.1093/europace/euz184. Europace. 2019. PMID: 31274152 Clinical Trial.
-
Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT).Trials. 2018 Nov 1;19(1):600. doi: 10.1186/s13063-018-2930-y. Trials. 2018. PMID: 30382923 Free PMC article.
-
Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.Eur J Heart Fail. 2016 Nov;18(11):1365-1374. doi: 10.1002/ejhf.530. Epub 2016 Apr 18. Eur J Heart Fail. 2016. PMID: 27087019 Clinical Trial.
-
Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.Dan Med J. 2014 Dec;61(12):B4981. Dan Med J. 2014. PMID: 25441737 Review.
-
Cardiac resynchronization therapy outcomes with left ventricular lead concordant with latest mechanical activation: A meta-analysis.Pacing Clin Electrophysiol. 2022 Aug;45(8):930-939. doi: 10.1111/pace.14549. Epub 2022 Jun 21. Pacing Clin Electrophysiol. 2022. PMID: 35687711 Free PMC article. Review.
Cited by
-
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.J Arrhythm. 2023 Aug 2;39(5):681-756. doi: 10.1002/joa3.12872. eCollection 2023 Oct. J Arrhythm. 2023. PMID: 37799799 Free PMC article.
-
Long-Term Performance of Epicardial versus Transvenous Left Ventricular Leads for Cardiac Resynchronization Therapy.J Clin Med. 2023 Sep 5;12(18):5766. doi: 10.3390/jcm12185766. J Clin Med. 2023. PMID: 37762709 Free PMC article.
-
Thoracoscopic Implantation of Epicardial Left Ventricular Lead for Cardiac Resynchronization Therapy.J Cardiovasc Dev Dis. 2022 May 16;9(5):160. doi: 10.3390/jcdd9050160. J Cardiovasc Dev Dis. 2022. PMID: 35621871 Free PMC article.
-
JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias.J Arrhythm. 2021 Jun 2;37(4):709-870. doi: 10.1002/joa3.12491. eCollection 2021 Aug. J Arrhythm. 2021. PMID: 34386109 Free PMC article. No abstract available.
-
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.Heart Rhythm. 2023 Sep;20(9):e17-e91. doi: 10.1016/j.hrthm.2023.03.1538. Epub 2023 May 20. Heart Rhythm. 2023. PMID: 37283271 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials